严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019年冠状病毒病(COVID-19)
免疫系统
病毒学
生物
医学
免疫学
内科学
传染病(医学专业)
疾病
作者
Sijie Yang,Yuanling Yu,Yanli Xu,Fanchong Jian,Weiliang Song,Ayijiang Yisimayi,Peng Wang,Jing Wang,Jingyi Liu,Lingling Yu,Xiaofeng Niu,Jing Wang,Yao Wang,Fei Shao,Ronghua Jin,Youchun Wang,Yunlong Cao
标识
DOI:10.1016/s1473-3099(23)00744-2
摘要
The SARS-CoV-2 saltation variant BA.2.86, which was quickly designated as a variant under monitoring after its emergence, has garnered global attention. Although BA.2.86 did not show substantial humoral immune escape and growth advantage compared with current dominant variants, such as EG.5.1 and HK.3, it showed remarkably high ACE2 binding affinity.1–5 This increased binding affinity, coupled with its distinct antigenicity, could enable BA.2.86 to accumulate immune-evasive mutations during low-level populational transmission, akin to the previous evolution from BA.2.75 to CH.1.1 and XBB.
科研通智能强力驱动
Strongly Powered by AbleSci AI